Armata Pharmaceuticals Inc (ARMP) — Cash Flow-to-Debt Ratio
Armata Pharmaceuticals Inc (ARMP) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of $-6.67 Million could theoretically repay 0% of its total liabilities ($295.48 Million) in one year. See how financially flexible is Armata Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Armata Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1993–2025)
Historical debt coverage capacity for Armata Pharmaceuticals Inc across 31 annual periods. For the full cash flow conversion analysis, see Armata Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Armata Pharmaceuticals Inc (1993–2025)
Year-by-year debt coverage analysis for Armata Pharmaceuticals Inc. Check Armata Pharmaceuticals Inc (ARMP) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | $-25.76 Million | $295.48 Million | ▲ +68.8% |
| 2024 | -0.28x | $-37.55 Million | $134.46 Million | ▲ +23.2% |
| 2023 | -0.36x | $-47.42 Million | $130.43 Million | ▲ +19.6% |
| 2022 | -0.45x | $-32.48 Million | $71.80 Million | ▲ +14.9% |
| 2021 | -0.53x | $-23.57 Million | $44.37 Million | ▲ +39.9% |
| 2020 | -0.88x | $-18.27 Million | $20.66 Million | ▲ +38.4% |
| 2019 | -1.44x | $-15.58 Million | $10.86 Million | ▲ +47.8% |
| 2018 | -2.75x | $-9.38 Million | $3.41 Million | ▼ -1.9% |
| 2017 | -2.70x | $-9.19 Million | $3.41 Million | ▼ -115.9% |
| 2016 | -1.25x | $-10.59 Million | $8.47 Million | ▼ -140.0% |
| 2015 | -0.52x | $-9.78 Million | $18.78 Million | ▼ -4.3% |
| 2014 | -0.50x | $-12.57 Million | $25.18 Million | ▼ -249.7% |
| 2013 | -0.14x | $-7.45 Million | $52.17 Million | ▲ +69.6% |
| 2012 | -0.47x | $-4.28 Million | $9.13 Million | ▲ +56.5% |
| 2011 | -1.08x | $-4.67 Million | $4.33 Million | ▼ -14.3% |
| 2008 | -0.94x | $-10.30 Million | $10.92 Million | ▲ +16.8% |
| 2007 | -1.13x | $-13.88 Million | $12.23 Million | ▼ -18.0% |
| 2006 | -0.96x | $-11.64 Million | $12.10 Million | ▼ -6.9% |
| 2005 | -0.90x | $-16.39 Million | $18.23 Million | ▼ -17.0% |
| 2004 | -0.77x | $-15.52 Million | $20.20 Million | ▼ -60.4% |
| 2003 | -0.48x | $-11.23 Million | $23.44 Million | ▼ -9.8% |
| 2002 | -0.44x | $-20.10 Million | $46.07 Million | ▲ +37.7% |
| 2001 | -0.70x | $-23.54 Million | $33.64 Million | ▼ -2736.7% |
| 2000 | -0.02x | $-605.54K | $24.54 Million | ▲ +98.4% |
| 1999 | -1.58x | $-10.60 Million | $6.70 Million | ▼ -14.6% |
| 1998 | -1.38x | $-5.80 Million | $4.20 Million | ▲ +53.6% |
| 1997 | -2.98x | $-12.50 Million | $4.20 Million | ▼ -60.3% |
| 1996 | -1.86x | $-10.40 Million | $5.60 Million | ▲ +8.2% |
| 1995 | -2.02x | $-8.50 Million | $4.20 Million | ▼ -6.8% |
| 1994 | -1.89x | $-7.20 Million | $3.80 Million | ▲ +18.2% |
| 1993 | -2.32x | $-4.40 Million | $1.90 Million | — |